EXECUTIVE ENGAGEMENTS
POOL
586
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
117
Interactions with Platform & by Email
PARTICIPANTS
23
Unique # Participated
VALIDATIONS
12
Responses Validated*
COMPANIES
34
Responses Validated*
* Login for a full stack data experience
DATE
JAN 2022
TABLES
22
PAGES
89
EDITION
7
PRICE
USD 5600
CODE
MCP21002
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
What's New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Amid the COVID-19 crisis, the global market for 3D Bioprinting estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$5 Billion by 2027, growing at a CAGR of 15.4% over the analysis period 2020-2027. Inkjet-based, one of the segments analyzed in the report, is projected to record a 16.1% CAGR and reach US$2.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Magnetic Levitation segment is readjusted to a revised 16.6% CAGR for the next 7-year period.
The 3D Bioprinting market in the U.S. is estimated at US$543 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$863.5 Million by the year 2027 trailing a CAGR of 14.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.7% and 13.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 11.2% CAGR.
In the global Laser-based segment, USA, Canada, Japan, China and Europe will drive the 10.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$135.1 Million in the year 2020 will reach a projected size of US$277.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$595.9 Million by the year 2027.
SELECT PLAYERS
3D Bioprinting Solutions; 3D Systems; Advanced Solutions Life Sciences; Allevi Inc.; Aspect Biosystems Ltd.; Bio3D Technologies; Cellink; Cellink Global; Cyfuse Biomedical K.K.; Digilab, Inc.; Envisiontec; Gesim; Inventia Life Science Pty Ltd.; Materialise NV; Nano3D Biosciences, Inc.; Oceanz 3D printing & Additive Manufacturing; Organovo Holdings, Inc.; Poietis; Regemat 3D S.L.; Regenhu; Regenovo Biotechnology Co., Ltd.; Rokit Healthcare; Solidscape; Stratasys Ltd.; Tevido Biodevices; Vivax Bio, LLC; Voxeljet
SEGMENTS
» Technology (Inkjet-based, Magnetic Levitation, Laser-based, Other Technology) » Material (Living Cells, Hydrogels, Extracellular Matrices, Other Materials) » End-Use (Research Organizations & Academic Institutes, Biopharmaceutical Companies, Hospitals)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 3D Bioprinting – Global Key Competitors Percentage Market Share in 2022 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Living Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Living Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Hydrogels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Hydrogels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Extracellular Matrices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Extracellular Matrices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Other Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Research Organizations & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Research Organizations & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World 3D Bioprinting Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027 |
| World Recent Past, Current & Future Analysis for 3D Bioprinting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for 3D Bioprinting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Inkjet-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Inkjet-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Magnetic Levitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Magnetic Levitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Laser-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Laser-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Other Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
| USA Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2021 & 2027 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2021 & 2027 |
| JAPAN |
| 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
| Japan Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2021 & 2027 |
| CHINA |
| 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
| China Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2021 & 2027 |
| China Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2021 & 2027 |
| China Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2021 & 2027 |
| EUROPE |
| 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
| Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for 3D Bioprinting by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2021 & 2027 |
| FRANCE |
| 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
| France Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2021 & 2027 |
| France Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2021 & 2027 |
| France Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2021 & 2027 |
| GERMANY |
| 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
| Germany Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2021 & 2027 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2021 & 2027 |
| UNITED KINGDOM |
| 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
| UK Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2021 & 2027 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2021 & 2027 |
| ASIA-PACIFIC |
| 3D Bioprinting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2021 & 2027 |
| REST OF WORLD |
| Rest of World Recent Past, Current & Future Analysis for 3D Bioprinting by Material - Living Cells, Hydrogels, Extracellular Matrices and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for 3D Bioprinting by Material - Percentage Breakdown of Value Sales for Living Cells, Hydrogels, Extracellular Matrices and Other Materials for the Years 2021 & 2027 |
| Rest of World Recent Past, Current & Future Analysis for 3D Bioprinting by End-Use - Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for 3D Bioprinting by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Hospitals and Research Organizations & Academic Institutes for the Years 2021 & 2027 |
| Rest of World Recent Past, Current & Future Analysis for 3D Bioprinting by Technology - Inkjet-based, Magnetic Levitation, Laser-based and Other Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for 3D Bioprinting by Technology - Percentage Breakdown of Value Sales for Inkjet-based, Magnetic Levitation, Laser-based and Other Technology for the Years 2021 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 34 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com